Close Menu

restructuring

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PerkinElmer reduced its number of employees by 72 as part of a restructuring plan during its recently completed second quarter, the company disclosed this week.

German molecular diagnostics firm Epigenomics today reported that its first-half revenues increased 1 percent year over year, and the firm is implementing a restructuring that will include cutting its staff by nearly half.

As part of the restructuring, Silence has lowered the headcount at its Berlin research facility to 27 from 32.

Silence said that the offering, if completed, would extend its cash runway from the third quarter of this year until mid-2012.

Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.

The Australian gel and protein detection firm sold its US subsidiary and its flagship technology in recent months and is now targeting acquisitions moving ahead.

Collins' "bold" plan to break up NCRR to catalyze translational science is drawing fire over its process and its plans for NCRR, as well as notes of caution from seasoned senators.

It was not immediately clear what impact the move would have on the programs overseen by the unit.

An article about an acquisition topped the list of the most-read stories for the year on GenomeWeb Daily News, while restructurings, lawsuits, and one firm's IPO plans made it into the top 10.

According to the company, it is responding to "mounting cost pressures in healthcare" and to "increasing hurdles for the approval and pricing of new medicines."

Pages

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.